Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent.
about
Pharmacological targeting of the mitochondrial phosphatase PTPMT1.Identification of structural features in chemicals associated with cancer drug response: a systematic data-driven analysis.Discovery of potent and selective inhibitors of Trypanosoma brucei ornithine decarboxylaseUse of parallel validation high-throughput screens to reduce false positives and identify novel dengue NS2B-NS3 protease inhibitors.Downregulation of the mitochondrial phosphatase PTPMT1 is sufficient to promote cancer cell deathSynthesis, characterization, DNA binding and cleavage, BSA interaction and anticancer activity of dinuclear zinc complexes.Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual and high-throughput screeningsBis-biguanide dihydrochloride inhibits intracellular replication of M. tuberculosis and controls infection in miceThe role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic.Epithelial ovarian cancer experimental models.Drugs for dengue: a patent review (2010-2014).Oral disinfectants inhibit protein-protein interactions mediated by the anti-apoptotic protein Bcl-xL and induce apoptosis in human oral tumor cells.Alexidine and chlorhexidine bind to lipopolysaccharide and lipoteichoic acid and prevent cell activation by antibiotics.Alexidine Dihydrochloride Attenuates Osteoclast Formation and Bone Resorption and Protects Against LPS-Induced Osteolysis.Computational Cell Cycle Profiling of Cancer Cells for Prioritizing FDA-Approved Drugs with Repurposing Potential.
P2860
Q30273891-EA846B10-852C-41CB-91A7-727D1ADC5DB5Q30845301-F1234553-D4CC-47DB-A2CD-E9C9EA5485A3Q33883491-DC40BFC8-CA99-485B-BA19-F58E7D7D050FQ34109411-5A728DB8-1A94-4343-92DF-2B81A437E895Q34323114-9A1990EE-7CDE-407E-919D-DD2BABE1E9E7Q34396926-034D758B-FE07-4D87-A5CB-933F1B924934Q35065902-5380F765-76DD-44D7-AA57-9999DA344A4BQ36124776-F71B4368-C0DE-4AA5-8C74-6519460E4012Q36809514-46E92D33-255B-43BC-97C3-DC3B0CE5FB8BQ37708938-72CF9D7A-E50D-41BA-9567-E2E763B07CFCQ38256785-5C814904-D942-4634-96F2-D3DC3794FF32Q39178267-BC05E86E-3B57-44E8-9506-553A6F3027C8Q39960201-DB0913CF-BEDA-424A-8C89-B5A94D42625DQ41003979-08A11FC1-D681-42BD-AE6E-404DEE757A17Q41195283-30F1B1BB-A0FD-47D2-A189-1143CE71F83A
P2860
Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent.
@ast
Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent.
@en
Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent.
@nl
type
label
Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent.
@ast
Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent.
@en
Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent.
@nl
prefLabel
Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent.
@ast
Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent.
@en
Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent.
@nl
P2093
P50
P1476
Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent.
@en
P2093
Carlo Bastianutto
Joseph D Mocanu
Kenneth W Yip
P Y Billie Au
Xinliang Mao
P304
P356
10.1158/1535-7163.MCT-06-0134
P577
2006-09-01T00:00:00Z